Section Arrow
ARMP.NYSE-M
- Armata Pharmaceuticals
Quotes are at least 15-min delayed:2024/05/16 15:57 EDT
Last
 2.63
-0.02 (-0.75%)
Day High 
Prev. Close
2.65 
1-M High
3.45 
Volume 
23.03K 
Bid
2.66
Ask
2.74
Day Low
2.52 
Open
2.94 
1-M Low
2.26 
Market Cap 
95.81M 
Currency USD 
P/E -- 
%Yield
10-SMA 2.82 
20-SMA 2.69 
50-SMA 3.23 
52-W High 5.2565 
52-W Low 1.0701 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-2.20/-1.57
Enterprise Value
206.70M
Balance Sheet
Book Value Per Share
-1.56
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1012+0.0235+30.24%-- 
DNAGinkgo Bioworks Holdings0.84+0.0009+0.11%-- 
NBYNovaBay Pharmaceuticals0.12005+0.01555+14.88%-- 
JAGXJaguar Health0.28426+0.02916+11.43%-- 
NVAXNovavax14.42+1.52+11.78%-- 
Quotes are at least 15-min delayed:2024/05/16 15:57 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.